Get started
Author

Lindsay Kaye Morris

Observed name: Lindsay K. Morris
Institution: Mayo Clinic
OpenAlex ID: A5113810789
Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT
2018 · Jaden D. Evans, Lindsay K. Morris, et al. · International Journal of Radiation Oncology*Biology*Physics · 30
An comparison of acute toxicities and patient‐reported outcomes between intensity‐modulated proton therapy and volumetric‐modulated arc therapy after ipsilateral radiation for head and neck cancers
2021 · Elizabeth B. Jeans, Satomi Shiraishi, et al. · Head & Neck · 13
Cost effectiveness of treatment strategies for high risk prostate cancer
2022 · Roman O. Kowalchuk, Hayeon Kim, et al. · Cancer · 11
Impact of margin status on survival after radical nephrectomy for renal cell carcinoma
2020 · Lindsay K. Morris, Alaa Altahan, et al. · Journal of Surgical Oncology · 6
Next-Generation Sequencing Identifies Novel RTK VUSs in Breast Cancer with an Emphasis on ROS1, ERBB4, ALK and NTRK3
2018 · Matthew K. Stein, Lindsay K. Morris, et al. · Pathology & Oncology Research · 5
A Radiomics-Based Classifier for the Progression of Oropharyngeal Cancer Treated with Definitive Radiotherapy
2023 · Darwin A. Garcia, Elizabeth B. Jeans, et al. · Cancers · 4
PDF
Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer
2023 · Roman O. Kowalchuk, Grant M. Spears, et al. · Frontiers in Oncology · 4
PDF
In silico analysis of non-synonymous SNPs (nsSNPs) and outcomes in non-small cell lung cancer (NSCLC) patients (pts) treated with immunotherapy (IT).
2017 · Kruti Patel, Matthew K Stein, et al. · Journal of Clinical Oncology · 2
JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing in Solid Tumor Patients
2018 · Matthew K. Stein, Lindsay K. Morris, et al. · Pathology & Oncology Research · 1
Distribution and pathogenicity of nsSNPs in receptor tyrosine kinases (RTKs) in non-small cell lung cancer (NSCLC) patients (pts).
2017 · Ari M. Vanderwalde, Matthew K Stein, et al. · Journal of Clinical Oncology · 1
PO30 Presentation Time: 10:30 AM
2022 · Lindsay K. Morris, Allison E. Garda, et al. · Brachytherapy
Distribution of receptor tyrosine kinase (RTK) nsSNPs in breast cancer (BC) patients (pts) using next-generation sequencing (NGS).
2017 · Lindsay Kaye Morris, Matthew Stein, et al. · Journal of Clinical Oncology
Localization of non-receptor tyrosine kinase (nRTK) variants in solid tumor patients using next-generation sequencing (NGS).
2017 · Srishti Sareen, Matthew Stein, et al. · Journal of Clinical Oncology
In silico analysis of DNA damage repair variants in advanced NSCLC patients (pts) to predict response to platinum-based chemotherapy (PBC).
2017 · Saradasri Karri, Matthew K Stein, et al. · Journal of Clinical Oncology
Impact of margin status on survival after radical nephrectomy for renal cell carcinoma (RCC).
2017 · Lindsay Kaye Morris, Alaa Altahan, et al. · Journal of Clinical Oncology
Distribution and pathogenicity of nsSNPs in receptor tyrosine kinases (RTKs) in patients with colorectal cancer.
2017 · Matthew K Stein, Saradasri Karri, et al. · Journal of Clinical Oncology
Expanding the search for significant EGFR mutations in NSCLC outside of the tyrosine kinase domain (TKD) with next-generation sequencing (NGS).
2017 · Matthew K Stein, Lindsay Kaye Morris, et al. · Journal of Clinical Oncology
Works count: 17
Citation count: 76
H-index: 5
I10-index: 3
Year
Topic
Type